HIGHLIGHTS
- who: Satarupa Sengupta and colleagues from the Children`s Hospital, Australia University of Colorado Denver have published the research: Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma, in the Journal: (JOURNAL)
- what: The aim of the initial experiment with radiation was to determine the IR doses to be used in combination with IMT.
- how: To test the efficacy of radiation therapy while minimizing its side effects the authors investigated the efficacy of the combination of IMT as a radiosensitizer in in_vitro and in_vivo models of group 3 MB telomerase . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.